Intensive care units (ICUs) face several challenges, including staff shortages, disjointed data systems, and ineffective decision-making processes. These issues lead to increased clinician burnout and suboptimal patient outcomes. Clinomic, a MedTech firm in Aachen, Germany, addresses these problems with its AI-powered assistant, Mona.
This innovative tool integrates real-time data from medical devices, automates administrative tasks, and provides actionable insights to improve workflows, reduce clinician workload, and enhance patient care. Its telemedicine features enable access to specialised care in remote regions while improving ICU efficiency and enabling predictive analytics for better outcomes.
Clinomic has raised €23 million in a Series B financing round, co-led by the DeepTech & Climate Fund (DTCF) and a private family office. This brings the total funding to $50.9M. The funding will support international expansion, product development, and the company’s mission to transform critical care through AI and data-driven solutions. The new capital will drive Clinomic’s mission to revolutionise critical care through technology. The funds will expand global operations, extend solutions to more healthcare systems, enhance AI and data-driven ICU capabilities, and improve critical care delivery.
Clinomic plans to expand its flagship product, Mona, an AI-driven platform that streamlines ICU workflows, reduces administrative burden, and provides real-time insights for better decision-making. The company will continue developing innovative tools that combine medical hardware, software, and data analysis to modernise intensive care units and accelerate Mona’s introduction to new markets and healthcare providers worldwide.
From hospital experience to healthcare innovation: The Clinomic story
Clinomic was founded in 2019 by Arne Peine, Gernot Marx, and Lukas Martin — intensive care physicians at RWTH Aachen University Hospital. The founders identified ICU workflow inefficiencies, including overwhelming data streams, administrative burdens, and fragmented systems that hampered optimal patient care. They set out to use AI and telemedicine to revolutionise acute and intensive care medicine.
The idea for Clinomic emerged from the founders’ firsthand experience as ICU physicians struggling with patient management inefficiencies. They observed doctors overwhelmed by data volume — up to 1,000 data points per hour per patient — often resorting to manual note-taking to stay updated. This challenge inspired them to create Mona, an AI-powered assistant designed to streamline workflows and improve decision-making.
The team started in a small room in Aachen with minimal resources, relying on public funding and European Union grants for early development. They gradually raised additional capital to scale production and refine their solutions.
The company is rooted in European intensive care medicine, medical digitalisation, and telemedicine and continues to transform acute and intensive care. This dynamic, fast-growing startup employs an interdisciplinary, international team of over 70 engineers, developers, data scientists, and doctors dedicated to improving patient and provider care.
Behind Clinomic’s flagship product, Mona
Mona, short for Medical On-Site Assistant, is a cutting-edge AI-powered bedside assistant explicitly designed for intensive care units (ICUs). Developed by Clinomic, Mona combines advanced technologies — artificial intelligence, speech recognition, and telemedicine — to streamline ICU workflows and improve patient care.
Mona aggregates patient information from various hospital departments, including vital signs, lab results, radiology reports, and physician notes. AI algorithms process this data to deliver actionable insights at the bedside. The virtual assistant responds to voice commands, eliminating the need for physical contact with screens or keyboards and reducing cross-contamination risks. Through natural language processing (NLP), Mona converts spoken observations into organised clinical notes, cutting documentation time up to 80%.
Mona facilitates remote consultations by connecting ICU staff with specialists worldwide through a secure telemedicine platform, enabling real-time collaboration and expert input on complex cases. Its algorithms also predict trends in patient data, flagging critical changes in lab values before they become life-threatening. Plus, Mona features a 24″ 4K touchscreen, eight AI-assisted microphones, a 180° camera, and 5G and WiFi connectivity, designed for seamless integration within the ICU environment.
Mona operates directly at the bedside, unlike systems such as Suki Abridge, Babylon Health, Mayo Clinic Virtual Assistant, and Teladoc Health, which require clinicians to use central computer stations. Its voice-activated interface enables hands-free use during crucial procedures. Beyond displaying data, Mona analyses trends for proactive recommendations and combines local data analysis with global expertise through remote consultations.
Mona has been implemented in over 40 hospitals across eight EU countries and is seeking FDA approval for U.S. market expansion, a crucial step toward global adoption. Its performance during the COVID-19 pandemic proved its ability to reduce administrative burden while enhancing critical decision-making.
